Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)"

Wouter Kok; Susan Stienen

doi:https://doi.org/10.1161/CIRCULATIONAHA.118.036445

Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)"

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	1910-1911
Journal	Circulation
Volume	138
Issue number	17
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.118.036445
Publication status	Published - 2018

Access to Document

https://doi.org/10.1161/CIRCULATIONAHA.118.036445

Cite this

Kok, W., & Stienen, S. (2018). Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)". Circulation, 138(17), 1910-1911. https://doi.org/10.1161/CIRCULATIONAHA.118.036445

Kok, Wouter ; Stienen, Susan. / Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)". In: Circulation. 2018 ; Vol. 138, No. 17. pp. 1910-1911.

@article{38b141eebbb54b9195923bd6d33e0d6a,

title = "Response by Kok and Stienen to Letter Regarding Article, {"}NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?){"}",

author = "Wouter Kok and Susan Stienen",

year = "2018",

doi = "https://doi.org/10.1161/CIRCULATIONAHA.118.036445",

language = "English",

volume = "138",

pages = "1910--1911",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "17",

}

Kok, W & Stienen, S 2018, 'Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)"', Circulation, vol. 138, no. 17, pp. 1910-1911. https://doi.org/10.1161/CIRCULATIONAHA.118.036445

Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)". / Kok, Wouter ; Stienen, Susan.
In: Circulation, Vol. 138, No. 17, 2018, p. 1910-1911.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)"

AU - Kok, Wouter

AU - Stienen, Susan

PY - 2018

Y1 - 2018

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055609635&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30354664

U2 - https://doi.org/10.1161/CIRCULATIONAHA.118.036445

DO - https://doi.org/10.1161/CIRCULATIONAHA.118.036445

M3 - Comment/Letter to the editor

C2 - 30354664

SN - 0009-7322

VL - 138

SP - 1910

EP - 1911

JO - Circulation

JF - Circulation

IS - 17

ER -

Kok W , Stienen S. Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)". Circulation. 2018;138(17):1910-1911. doi: https://doi.org/10.1161/CIRCULATIONAHA.118.036445

Access to Document

Other files and links

Cite this